glp-1 agonist gastric emptying Gastrointestinal effects of receptor agonists: mechanisms, management, and future directions GLP-1 Receptor Agonists – Peripheral

Over the last 10 years, prescribing GLP-1RAs has become increasingly prevalent due to their significant impact on diabetes disease control, weight loss, and cardiovascular disease risk reduction

Unlike semaglutide, tirzepatide is a dual receptor agonist targeting both GLP1R and GIPR

It also promotes hepatic fat oxidation, which is a fancy way of saying it tells your liver to burn stored fat for fuel

Growing Awareness and Acceptance of GLP-1 Therapies There is a notable increase in awareness and acceptance of GLP-1 therapies among both healthcare professionals and patients

Figure 10: Diagram of the RIA method together with photographs of Professor Rosalyn Yalow (top) and Professor Solomon Berson (bottom)

Both have changed what is possible with non-surgical weight loss, and there is now head-to-head clinical data showing how they stack up against each other